AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18055296
Drug: Lightwand-guided endotracheal
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lightwand-guided endotracheal intubation with left hand (group L; n = 80)
Trial: 16086927
Drug: Omapatrilat (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat (40 mg every day)
Trial: 10473964
Drug: Topical retinaldehyde
RxNorm normalized name: retinaldehyde
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical retinaldehyde (RAL)
Trial: 31464895
Drug: Fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented milk containing Lactobacillus paracasei HP7 and Glycyrrhiza glabra, administered once daily for 8 weeks
Trial: 31464895
Drug: Placebo (fermented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (fermented milk only), administered once daily for 8 weeks
Trial: 25927622
Drug: Baclofen treatment
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen treatment (up to 60 mg/day)
Trial: 23992649
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg benfotiamine once daily for 24 weeks
Trial: 24844271
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 24 weeks
Trial: 11488769
Drug: Nonmetformin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonmetformin therapy
Trial: 9754983
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 1 week + NSAID (diclofenac 50 mg bid)
Trial: 9754983
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 1 week + NSAID (naproxen 250 mg bid)
Trial: 9754983
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 1 week + NSAID (piroxicam 10 mg om)
Trial: 9754983
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily for 1 week
Trial: 2959967
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate (2 g daily for 4 weeks)
Trial: 27143787
Drug: Shared canister
RxNorm normalized name: talc
DrugBank: Talc (DB09511)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Shared canister MDI therapy
Trial: 27143787
Drug: Single-patient canister
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-patient canister therapy
Trial: 25543218
Drug: Morphine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (1 mg/mL) alone for PCA (Group M)
Trial: 25543218
Drug: Morphine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (1 mg/mL) combined with dezocine (0.05 mg/mL) at a ratio of 20:1 for PCA (Group MD1)
Trial: 25543218
Drug: Morphine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (1 mg/mL) combined with dezocine (0.1 mg/mL) at a ratio of 10:1 for PCA (Group MD2)
Trial: 23545914
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel with 4% Quassia amara extract
Trial: 23545914
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel with 2% ketoconazole
Trial: 23545914
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel with 1% ciclopiroxolamine
Trial: 17169231
Drug: Self-collected vaginal-rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-collected vaginal-rectal swabs
Trial: 17169231
Drug: Clinician-collected vaginal-rectal
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-collected vaginal-rectal swabs
Trial: 12829672
Drug: Motexafin gadolinium
RxNorm normalized name: Motexafin gadolinium
DrugBank: Motexafin gadolinium (DB05428)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motexafin gadolinium (MGd) 5 mg/kg/d
Trial: 12829672
Drug: Whole-brain radiation
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-brain radiation therapy (WBRT) 30 Gy
Trial: 10626701
Drug: High-velocity, low-amplitude
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-velocity, low-amplitude spinal manipulation plus soft tissue therapy 2 to 3 times in the week before menses for at least 3 cycles
Trial: 10626701
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment with a spring-loaded adjusting instrument wound down for minimum force
Trial: 7555936
Drug: Omeprazole (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (n = 45), initial dose of 80 mg followed by 40 mg every eight hours for four days, then oral administration
Trial: 7555936
Drug: Ranitidine (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (n = 41), 50 mg every six hours for 12 to 24 hours, then oral administration
Trial: 2008873
Drug: Olestra (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olestra (20 g/d)
Trial: 6129179
Drug: Thioctic acid
RxNorm normalized name: Thioctic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioctic acid (alpha-lipoic acid), 300 mg/day
Trial: 25601342
Drug: Standard-dose chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose chemoradiotherapy (60 Gy)
Trial: 25601342
Drug: High-dose chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemoradiotherapy (74 Gy)
Trial: 25601342
Drug: Cetuximab with
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab with standard-dose chemoradiotherapy (60 Gy)
Trial: 25601342
Drug: No cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: No cetuximab with standard-dose chemoradiotherapy (60 Gy)
Trial: 25601342
Drug: High-dose chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemoradiotherapy with cetuximab (74 Gy)
Trial: 23784615
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (60,000 IU administered intravenously within 3 hours after PCI)
Trial: 23784615
Drug: Standard optimal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard optimal medical treatment
Trial: 21315654
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg preladenant
Trial: 21315654
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg preladenant
Trial: 21315654
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg preladenant
Trial: 21315654
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg preladenant
Trial: 16310713
Drug: 0.33 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.33 mg/kg oral active placebo (diphenhydramine)
Trial: 11124360
Drug: both preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: both preparations
Trial: 9286937
Drug: Aspirin (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (320 mg/d)
Trial: 9286937
Drug: Indobufen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen (200 mg BID)
Trial: 26696645
Drug: Hypothermia group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermia group (standard medical treatment plus endovascular hypothermia with a target temperature of 33 or 34°C for a minimum of 24 hours)
Trial: 26696645
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard medical treatment only with a target temperature of normothermia)
Trial: 24929428
Drug: Low-glycemic-load diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-glycemic-load diet with ALA and MUFA (canola oil-enriched bread supplement, 31 g canola oil per 2,000 kcal)
Trial: 24929428
Drug: Whole-grain diet
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain diet with whole-wheat bread supplement (control)
Trial: 24929428
Drug: Low-glycemic-load diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-glycemic-load diet with ALA and MUFA (canola oil-enriched bread supplement)
Trial: 12808702
Drug: PFME therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFME therapy with health education program
Trial: 12808702
Drug: PFME therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFME therapy alone
Trial: 12808702
Drug: PFME therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFME therapy
Trial: 8869311
Drug: Standard 18-G
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard 18-G Teflon cannula, removed on completion of infusion, rotated to contralateral arm daily (Group 1)
Trial: 8869311
Drug: Similar catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Similar catheter sited in each forearm, rotation of side of infusion daily (Group 2)
Trial: 8869311
Drug: 15-cm Silastic
RxNorm normalized name: CATHETER SILASTIC 14FR 5CC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-cm Silastic rubber catheter in one forearm and standard cannula in contralateral forearm, alternation of infusion daily (Group 3)
Trial: 8869311
Drug: Fine-bore 23-G
RxNorm normalized name: calcium gluconate
DrugBank: Calcium gluconate (DB11126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fine-bore 23-G silicone catheter sited in one arm only, fed continuously over 24 hours (Group 4)
Trial: 1505607
Drug: Nicardipine 60
RxNorm normalized name: niCARdipine 60 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 60 mg/day, in three spaced doses for one month
Trial: 26939716
Drug: Control condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control condition of standard secondary and specialist primary care treatment
Trial: 17309330
Drug: Cervarix vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervarix vaccine (bivalent L1 virus-like particle vaccine against HPV types 16 and 18)
Trial: 11752031
Drug: Prednisolone and
RxNorm normalized name: prednisolone and mydriatics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone and cytotoxic agents
Trial: 11752031
Drug: Low-dose cyclophosphamide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclophosphamide then azathioprine
Trial: 12316339
Drug: Combined low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined low-dose estrogen and progesterone pills
Trial: 843794
Drug: Dipyridamole (alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (alone and in combination with aspirin)
Trial: 29406177
Drug: Thirst-driven fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thirst-driven fluid administration (200 ml bolus triggered by participants)
Trial: 29406177
Drug: Thirst-driven fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thirst-driven fluid administration
Trial: 29406177
Drug: Clinician-directed fluid
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-directed fluid management (1.25 ml kg‐1 h‐1 with 500 ml bolus)
Trial: 23328379
Drug: CIK via
RxNorm normalized name: Human parathyroid hormone (PTH) synthetic peptide fragment (1-34), conjugated at the N-terminal amino group via a cleavable linker to O-methylpolyethylene glycol (2 x 20 kDa mPEG); 2-methylalanyl-(1-34)-peptide of parathyroid hormone (Homo sapiens parath
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIK via intravenous drop infusion for more than 6 times (study group)
Trial: 18611068
Drug: Anti-adhesion molecule
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-adhesion molecule therapy; specific agents not mentioned
Trial: 18611068
Drug: Anti-TNF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF therapy (infliximab, adalimumab)
Trial: 16025962
Drug: Puerarin injection
RxNorm normalized name: PUERARIA MIRIFICA ROOT
DrugBank: Puerarin (DB12290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Puerarin injection (PI)
Trial: 11432713
Drug: Vitamins/mineral and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins/mineral and garlic preparation
Trial: 2907349
Drug: bopindolol, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol, 1 mg once daily for 1 week
Trial: 2907349
Drug: atenolol, 50
RxNorm normalized name: Atenolol, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol, 50 mg once daily for 1 week
Trial: 2907349
Drug: adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: adrenaline infusion (20 ng/kg per min)
Trial: 1929842
Drug: Allopurinol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (50 mg per rectum, four times per day)
Trial: 1929842
Drug: Dimethyl sulfoxide
RxNorm normalized name: Dimethyl Sulfoxide
DrugBank: Dimethyl sulfoxide (DB01093)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dimethyl sulfoxide (500 mg per rectum, four times per day)
Trial: 1929842
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no radical scavengers, only analgesic regimen)
Trial: 324238
Drug: G 31.406
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G 31.406
Trial: 9676837
Drug: Oral 13‐cis‐retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 13‐cis‐retinoic acid at a dose of 1 mg/kg
Trial: 7740961
Drug: Timopentina (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timopentina (50 mg/3 times per week for 6 weeks, 4 or 5 cycles during the year)
Trial: 2691169
Drug: Experimental dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental dental rinse (15 ml, rinsed for 30 seconds)
Trial: 5332751
Drug: Analgesic-sedative combination
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic-sedative combination (Fiorinal-C(1/4))
Trial: 5332751
Drug: Analgesic (APC-C)
RxNorm normalized name: ANALGESIC CREAM
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic (APC-C)
Trial: 27138893
Drug: School-based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based Cognitive Behavioural Therapy (CBT)
Trial: 26702925
Drug: Ceftaroline fosamil
RxNorm normalized name: Ceftaroline fosamil
DrugBank: Ceftaroline fosamil (DB06590)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftaroline fosamil (600 mg every 12 h)
Trial: 8215267
Drug: Ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (2 g every 24 h)
Trial: 21571593
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg fingolimod
Trial: 21571593
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg fingolimod
Trial: 21571593
Drug: Interferon beta‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta‐1a to 0.5 mg fingolimod
Trial: 21571593
Drug: Interferon beta‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta‐1a to 1.25 mg fingolimod
Trial: 17171925
Drug: High-dose fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fentanyl (75 microg/kg followed by 0.3 microg/kg/min)
Trial: 17171925
Drug: Diazepam-ketamine (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam-ketamine (0.8 mg/kg D and 2 mg/kg K followed by 0.07 mg/kg/h D and 1 mg/kg/h K)
Trial: 30514262
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg bis in die)
Trial: 30514262
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin and metformin
Trial: 30514262
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and Metformin
Trial: 20922480
Drug: Workload score
RxNorm normalized name: fecal microbiota spores, live Oral Capsule [Vowst]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Workload score based on the number of drugs involved, type of literature search performed, and judgmental categorization.
Trial: 20922480
Drug: Number of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Number of drugs involved.
Trial: 10029561
Drug: Formoterol, 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol, 12 microg once daily
Trial: 10029561
Drug: Formoterol, 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol, 6 microg twice daily
Trial: 10029561
Drug: Formoterol, 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol, 24 microg twice daily
Trial: 10029561
Drug: Terbutaline, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline, 500 microg four times daily
Trial: 10029561
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of formoterol (12 microg once daily or 6 microg twice daily)
Trial: 7479225
Drug: Propranolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.1 mg/kg) and atropine (0.02 mg/kg)
Trial: 4065106
Drug: Domperidone, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone, 10 mg
Trial: 4065106
Drug: Atropine, 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine, 0.6 mg
Trial: 31487627
Drug: Alternative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatment
Trial: 27866177
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (4 oz daily for 6 months)
Trial: 22816441
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all devices
Trial: 12548091
Drug: Intravenous treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous treprostinil
Trial: 18536066
Drug: WSKY capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WSKY capsule added on risperidone
Trial: 15572397
Drug: Retrospective dosimetry
RxNorm normalized name: 3-iodobenzylguanidine
DrugBank: Iobenguane (DB06704)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrospective dosimetry using FISH translocations for patients with lower earlier dose estimates (up to about 3 Gy)
Trial: 15572397
Drug: Retrospective dosimetry
RxNorm normalized name: 3-iodobenzylguanidine
DrugBank: Iobenguane (DB06704)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrospective dosimetry using FISH translocations for patients with higher earlier dose estimates (up to about 12 Gy)
Trial: 10471984
Drug: Gabapentin 400
RxNorm normalized name: gabapentin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 400 mg three times daily for 2 weeks
Trial: 10471984
Drug: Phenytoin 100
RxNorm normalized name: phenytoin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin 100 mg three times daily for 2 weeks
Trial: 8560996
Drug: Minprostin gel
RxNorm normalized name: Minprostin F2 Alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minprostin gel (0.5 mg intracervical Gel)
Trial: 8560996
Drug: Minprostin tablets
RxNorm normalized name: Minprostin F2 Alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minprostin tablets (3 mg vaginal tablets)
Trial: 8478315
Drug: Dirithromycin (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dirithromycin (two 250 mg tablets, once daily)
Trial: 8478315
Drug: Erythromycin (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (four 250 mg tablets, four times daily)
Trial: 29254080
Drug: 20-mg telmisartan
RxNorm normalized name: telmisartan 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg telmisartan (Micardis)
Trial: 29254080
Drug: 40-mg telmisartan
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-mg telmisartan (Micardis)
Trial: 24257146
Drug: Subfascial catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subfascial catheter with continuous levobupivacaine infusion (Group S)
Trial: 24257146
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with continuous levobupivacaine infusion (Group E)
Trial: 23109696
Drug: CAP45 (45-Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAP45 (45-Gy RT for 5 weeks with concurrent capecitabine)
Trial: 23109696
Drug: CAPOX50 (50-Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAPOX50 (50-Gy RT for 5 weeks with concurrent capecitabine and oxaliplatin)